Reducing Alcohol use among Elective Surgical Patients using Adaptive Interventions

使用适应性干预措施减少择期手术患者的饮酒量

基本信息

项目摘要

Project Summary/Abstract Surgery is a pivotal life event during which the acuity and imminence of surgical risk can motivate patients to make major changes to behaviors and lifestyle factors to optimize surgical health. Preoperative alcohol consumption (>2 drinks a day) is a common surgical risk factor linked to increased postoperative complications. Appropriately timed interventions could promote short- and long-term alcohol use reduction and prevent excess surgical morbidity and mortality. However, the dearth of research in this area limits our ability to intervene effectively or leverage motivation at critical time points. This study uses a sequential, multiple assignment, randomized trial (SMART) to test the efficacy of adaptive interventions for elective surgical patients reporting high-risk alcohol use. These adaptive interventions use decision rules at critical points during the surgical episode of care to modify treatment type and intensity based on early treatment response. The specific aims are: 1) Test the efficacy of adaptive interventions that begin with preoperative ‘Virtual Coaching’ relative to Enhanced Usual Care on reducing alcohol use, surgical complications, and hospital length of stay; and 2) Identify the most efficacious second-stage intervention to sustained alcohol use reduction after surgery among early treatment responders and non-responders. Elective surgical patients (N = 440) will be randomized before surgery to either Virtual Coaching or Enhanced Usual Care. Initial treatment response will be assessed at the 2-month follow up for the perioperative period. Early responders (i.e., abstinence or low-risk alcohol use) will be re-randomized to postoperative strategies, either continued Virtual Coaching or stepped down to Usual Care. Early non-responders (i.e., not abstinent or low risk drinking), will be re-randomized to alternative postoperative strategies, either ‘On-track,’ a mobile health intervention that incorporates self- monitoring and progress feedback, or a combined intervention (Virtual Coaching + On-Track). Outcomes will be measured at 2-, 6-, and 12-month follow-ups and via electronic health records. Secondary aims are: 1) Identify the best performing adaptive interventions; and 2) Identify baseline and time varying moderators of intervention efficacy. Results of this study will have wide-ranging implications for innovating and moving beyond static alcohol interventions in healthcare settings and will advance surgical health optimization research. This study is consistent with the priorities of the National Institute of Alcohol Abuse and Alcoholism which seeks to advance addiction health services by integrating alcohol treatment into mainstream healthcare, thereby improving access and decreasing stigma. The adaptive interventions developed in this study enables real-time treatment tailoring based on individual’s response to first stage interventions, a critical advance in care consistent with national precision health priorities which seek to tailor treatment to individual needs.
项目摘要/摘要 手术是人生的关键事件,在此期间手术风险的敏锐性和迫在眉睫可以激励患者 对行为和生活方式因素进行重大改变,以优化手术健康。术前酒精 饮酒(每天两杯)是手术后增加的常见风险因素。 并发症。适当时机的干预可以促进短期和长期酒精使用的减少和 防止过高的外科发病率和死亡率。然而,这方面研究的匮乏限制了我们的能力 在关键时刻进行有效干预或利用动力。这项研究使用了顺序、多次 随机试验(SMART)测试择期手术适应性干预效果的分配 报告高风险饮酒的患者。这些适应性干预在关键时刻使用决策规则 根据早期治疗反应调整治疗类型和强度的手术护理。这个 具体目标是:1)测试从术前虚拟教练开始的适应性干预的有效性 与加强日常护理相比,减少酒精使用、手术并发症和住院时间; 2)确定手术后持续减少酒精使用的最有效的第二阶段干预 在早期治疗应答者和无应答者中。择期手术患者(N=440)将 手术前随机接受虚拟教练或增强型日常护理。初步治疗反应将 在围手术期2个月的随访中进行评估。早期响应者(即禁欲或低风险 酒精使用)将被重新随机化为术后策略,要么是继续虚拟教练,要么是步进式 降到日常护理。早期无反应者(即不禁酒或低风险饮酒)将被重新随机分配到 另一种术后策略,要么是在轨道上,要么是一种结合了自我治疗的移动健康干预 监控和进度反馈,或组合干预(虚拟教练+跟踪)。结果将会 在2个月、6个月和12个月的随访中并通过电子健康记录进行测量。次要目标是:1) 确定最佳的适应性干预措施;以及2)确定基线和随时间变化的主持人 干预效果。这项研究的结果将对创新和移动具有广泛的影响 在医疗保健环境中超越静态酒精干预,并将促进外科健康优化 研究。这项研究与国家酒精滥用和酒精中毒研究所的优先事项一致 该组织寻求通过将酒精治疗纳入主流医疗来推进成瘾健康服务, 从而改善了可获得性并减少了耻辱。这项研究中开发的适应性干预措施使 根据个体对第一阶段干预的反应进行实时治疗定制,这是在 护理符合国家精确的卫生优先事项,寻求根据个人需求量身定做治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anne Christie Fernandez其他文献

Anne Christie Fernandez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anne Christie Fernandez', 18)}}的其他基金

4/4: The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopsychosocial Outcomes of Early Liver Transplant for Alcohol-Associated Liver Disease
4/4:综合研究:评估综合护理以改善酒精相关性肝病早期肝移植的生物心理社会结果
  • 批准号:
    10710711
  • 财政年份:
    2023
  • 资助金额:
    $ 62.4万
  • 项目类别:
Reducing Alcohol use among Elective Surgical Patients using Adaptive Interventions
使用适应性干预措施减少择期手术患者的饮酒量
  • 批准号:
    10337940
  • 财政年份:
    2022
  • 资助金额:
    $ 62.4万
  • 项目类别:
Leveraging electronic health records to identify risky alcohol use prior to surgery
利用电子健康记录在手术前识别危险的饮酒情况
  • 批准号:
    10213578
  • 财政年份:
    2020
  • 资助金额:
    $ 62.4万
  • 项目类别:
Leveraging electronic health records to identify risky alcohol use prior to surgery
利用电子健康记录在手术前识别危险的饮酒情况
  • 批准号:
    10604757
  • 财政年份:
    2020
  • 资助金额:
    $ 62.4万
  • 项目类别:
Leveraging electronic health records to identify risky alcohol use prior to surgery
利用电子健康记录在手术前识别危险的饮酒情况
  • 批准号:
    10676250
  • 财政年份:
    2020
  • 资助金额:
    $ 62.4万
  • 项目类别:
Integrating Alcohol Screening, Brief Intervention, and Referral to Treatment into Presurgical Care
将酒精筛查、短暂干预和转诊治疗纳入术前护理
  • 批准号:
    9355372
  • 财政年份:
    2016
  • 资助金额:
    $ 62.4万
  • 项目类别:
Integrating Alcohol Screening, Brief Intervention, and Referral to Treatment into Presurgical Care
将酒精筛查、短暂干预和转诊治疗纳入术前护理
  • 批准号:
    9032886
  • 财政年份:
    2016
  • 资助金额:
    $ 62.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了